HK1033271A1 - Multiparticulate pharmaceutical form with programmed and timed release and preparation method - Google Patents

Multiparticulate pharmaceutical form with programmed and timed release and preparation method

Info

Publication number
HK1033271A1
HK1033271A1 HK01103971A HK01103971A HK1033271A1 HK 1033271 A1 HK1033271 A1 HK 1033271A1 HK 01103971 A HK01103971 A HK 01103971A HK 01103971 A HK01103971 A HK 01103971A HK 1033271 A1 HK1033271 A1 HK 1033271A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical form
active principle
timed release
polymer
hours
Prior art date
Application number
HK01103971A
Other languages
English (en)
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Original Assignee
Prographarm Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prographarm Lab filed Critical Prographarm Lab
Publication of HK1033271A1 publication Critical patent/HK1033271A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01103971A 1998-05-20 2001-06-11 Multiparticulate pharmaceutical form with programmed and timed release and preparation method HK1033271A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (1)

Publication Number Publication Date
HK1033271A1 true HK1033271A1 (en) 2001-08-24

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103971A HK1033271A1 (en) 1998-05-20 2001-06-11 Multiparticulate pharmaceutical form with programmed and timed release and preparation method

Country Status (25)

Country Link
EP (1) EP1077687B1 (ko)
JP (1) JP2002515423A (ko)
KR (1) KR100583065B1 (ko)
CN (1) CN1186014C (ko)
AT (1) ATE214598T1 (ko)
AU (1) AU758299B2 (ko)
BG (1) BG64764B1 (ko)
BR (1) BR9910606A (ko)
CA (1) CA2333188C (ko)
DE (1) DE69901062T2 (ko)
DK (1) DK1077687T3 (ko)
ES (1) ES2173739T3 (ko)
FR (1) FR2778848B1 (ko)
GE (1) GEP20022750B (ko)
HK (1) HK1033271A1 (ko)
HU (1) HU224193B1 (ko)
IL (1) IL139774A (ko)
MX (1) MXPA00011364A (ko)
NO (1) NO330501B1 (ko)
NZ (1) NZ508392A (ko)
PL (1) PL192950B1 (ko)
PT (1) PT1077687E (ko)
TR (1) TR200100107T2 (ko)
WO (1) WO1999059557A1 (ko)
ZA (1) ZA200006768B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
CN1305371A (zh) 2001-07-25
GEP20022750B (en) 2002-08-26
BG104963A (en) 2001-07-31
AU3830299A (en) 1999-12-06
PT1077687E (pt) 2002-09-30
PL192950B1 (pl) 2006-12-29
NZ508392A (en) 2002-09-27
FR2778848A1 (fr) 1999-11-26
ATE214598T1 (de) 2002-04-15
TR200100107T2 (tr) 2001-06-21
CA2333188A1 (fr) 1999-11-25
DK1077687T3 (da) 2002-06-17
BR9910606A (pt) 2001-10-02
DE69901062T2 (de) 2002-10-31
KR20010052370A (ko) 2001-06-25
AU758299B2 (en) 2003-03-20
EP1077687A1 (fr) 2001-02-28
HUP0102027A2 (hu) 2002-03-28
MXPA00011364A (es) 2008-09-09
BG64764B1 (bg) 2006-03-31
WO1999059557A1 (fr) 1999-11-25
ES2173739T3 (es) 2002-10-16
IL139774A0 (en) 2002-02-10
NO330501B1 (no) 2011-05-02
NO20005838D0 (no) 2000-11-17
HUP0102027A3 (en) 2002-12-28
HU224193B1 (hu) 2005-06-28
EP1077687B1 (fr) 2002-03-20
PL344314A1 (en) 2001-10-22
DE69901062D1 (de) 2002-04-25
FR2778848B1 (fr) 2001-11-23
NO20005838L (no) 2001-01-10
CA2333188C (fr) 2010-07-06
IL139774A (en) 2005-09-25
JP2002515423A (ja) 2002-05-28
KR100583065B1 (ko) 2006-06-08
ZA200006768B (en) 2001-11-20
CN1186014C (zh) 2005-01-26

Similar Documents

Publication Publication Date Title
HK1033271A1 (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method
AU2001239658A1 (en) Method for producing a controlled-release preparation
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
CA2351814A1 (en) Taste masked pharmaceutical particles
CA2141582A1 (en) Pelletised pharmaceutical composition
PT1207860E (pt) Formulação de peletes de libertação controlada
ATE204747T1 (de) Retard-matrixpellets und verfahren zu ihrer herstellung
IL151150A0 (en) Multiparticulate drug form comprising at least two differently coated pellet forms
IL127378A0 (en) Enteric coating for an oral preparation
WO2001034119A3 (en) Inhibitors of crystallization in a solid dispersion
NO20013336D0 (no) Farmasöytiske preparater
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
EP0616802A4 (en) PREPARATION ORALLY ADMINISTERED TO BE RELEASED IN THE LOWER DIGESTIVE TUBE.
AU574220B2 (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
DK1417960T3 (da) Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
WO2006006691A3 (en) Solid dispersion of a p38 map kinase inhibitor
TH51671A3 (th) องค์ประกอบทางเภสัชกรรมที่เคลือบเอนเทอริค และวิธีการผลิต
TH61893C3 (th) องค์ประกอบทางเภสัชกรรมที่เคลือบเอนเทอริค และวิธีการผลิต

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20190519